Laekna, Inc. (HKG:2105)
Hong Kong · Delayed Price · Currency is HKD 13.02
+0.22 (1.72%)
At close: Mar 6, 2026
Laekna Market Cap
Laekna has a market cap or net worth of 5.45 billion as of March 6, 2026. Its market cap has increased by 51.51% in one year.
Market Cap
5.45B
Enterprise Value
4.76B
Revenue
5.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.02
Market Cap Chart
Since June 29, 2023, Laekna's market cap has decreased from 5.85B to 5.45B, a decrease of -6.94%. That is a compound annual growth rate of -2.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 5.35B | -5.67% |
| Dec 31, 2025 | 5.68B | 62.12% |
| Dec 31, 2024 | 3.50B | -54.90% |
| Dec 29, 2023 | 7.76B | 32.67% |
| Jun 29, 2023 | 5.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CARsgen Therapeutics Holdings | 6.36B |
| Ocumension Therapeutics | 5.26B |
| Beijing Luzhu Biotechnology | 4.87B |
| Viva Biotech Holdings | 4.41B |
| Shandong Boan Biotechnology | 4.39B |
| Jacobio Pharmaceuticals Group | 4.31B |
| Mirxes Holding Company | 4.13B |
| TYK Medicines | 3.94B |